Etretinate

Etretinate is a lipid of Prenol Lipids (PR) class. Etretinate is associated with abnormalities such as Psoriasis, Skin lesion, Scleroderma, Chronic graft-versus-host disease and Evaluable Disease. The involved functions are known as Agent, Ulcer and Teratogenesis. Etretinate often locates in Hepatic and Skin. The related lipids are Steroids and Steroid, Systemic.

Cross Reference

Introduction

To understand associated biological information of Etretinate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Etretinate?

Etretinate is suspected in Scleroderma, Chronic graft-versus-host disease, Psoriasis, Skin lesion, Evaluable Disease, Pneumonia, Bacterial and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

No disease MeSH terms mapped to the current reference collection.

PubChem Associated disorders and diseases

What pathways are associated with Etretinate

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Etretinate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Etretinate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Etretinate?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Etretinate?

There are no associated biomedical information in the current reference collection.

What common seen animal models are associated with Etretinate?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Etretinate

Download all related citations
Per page 10 20 50 100 | Total 1071
Authors Title Published Journal PubMed Link
Mashiko M et al. Bacterial infection-induced generalized Hailey-Hailey disease successfully treated by etretinate. 2006 Clin. Exp. Dermatol. pmid:16309483
Okuyama R and Tagami H Psoriasis verrucosa in an obese Japanese man; a prompt clinical response observed with oral etretinate. 2006 J Eur Acad Dermatol Venereol pmid:17062076
Asano Y et al. Generalized granuloma annulare treated with short-term administration of etretinate. 2006 J. Am. Acad. Dermatol. pmid:16631959
Akiyama M et al. Compound heterozygous mutations including a de novo missense mutation in ABCA12 led to a case of harlequin ichthyosis with moderate clinical severity. 2006 J. Invest. Dermatol. pmid:16675967
Yanagi T et al. Epidermodysplasia verruciformis and generalized verrucosis: the same disease? 2006 Clin. Exp. Dermatol. pmid:16681585
Inozume T et al. Successful use of etretinate for long-term management of a patient with cutaneous-type adult T-cell leukaemia/lymphoma. 2005 Br. J. Dermatol. pmid:16307674
Seishima M et al. Thrombocytopenia possibly induced by etretinate in a psoriatic patient. 2005 J. Dermatol. pmid:16361755
Ikeda T et al. The effects of vitamin A derivative etretinate on the skin of MRL mice. 2005 Lupus pmid:16130505
Yamamoto T et al. Evaluation of psoriatic patients with HCV infection. 2005 J. Dermatol. pmid:16361725
Bukhari IA Impetigo herpetiformis in a primigravida: successful treatment with etretinate. 2004 Jul-Aug J Drugs Dermatol pmid:15303793
Horikoshi M et al. Punctate palmoplantar keratoderma with pigmentary lesions on the dorsa of feet and ankles: successful treatment with a combination of low-dose oral etretinate and topical calcipotriol. 2004 J. Dermatol. pmid:15235186
Yamamoto T et al. Temporomandibular arthritis in a patient with psoriasis vulgaris under systemic etretinate therapy. 2004 Dermatology (Basel) pmid:15237278
De Graaf YG et al. Systemic and topical retinoids in the management of skin cancer in organ transplant recipients. 2004 Dermatol Surg pmid:15061851
Fujimura T et al. CCR4 Expression by atypical T cells in systemic pilotropic lymphoma: its behavior under treatment with interferon gamma, topical PUVA and systemic retinoid. 2004 Dermatology (Basel) pmid:15118371
Suzuki K et al. Localized Darier's disease of the scalp: successful treatment with oral etretinate. 2004 Dermatology (Basel) pmid:14730246
Launay F et al. [Sneddon-Wilkinson disease. Four cases report]. 2004 Rev Med Interne pmid:14744648
Ikeda T et al. The Vitamin A derivative etretinate improves skin sclerosis in patients with systemic sclerosis. 2004 J. Dermatol. Sci. pmid:14757285
Kobayashi H and Tagami H Functional properties of the surface of the vermilion border of the lips are distinct from those of the facial skin. 2004 Br. J. Dermatol. pmid:15030342
Shimizu S et al. Dramatic efficacy of oral aromatic retinoid in long-standing hypertrophic lupus erythematosus. 2004 Acta Derm. Venereol. pmid:15844651
Fraunfelder FW and Fraunfelder FT Evidence for a probable causal relationship between tretinoin, acitretin, and etretinate and intracranial hypertension. 2004 J Neuroophthalmol pmid:15348987